Nea 15 Gp, Llc - Net Worth and Insider Trading

Nea 15 Gp, Llc Net Worth

The estimated net worth of Nea 15 Gp, Llc is at least $29 Million dollars as of 2024-12-03. Nea 15 Gp, Llc is the 10% Owner of Ardelyx Inc and owns about 5,331,039 shares of Ardelyx Inc (ARDX) stock worth over $29 Million. Details can be seen in Nea 15 Gp, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nea 15 Gp, Llc has not made any transactions after 2016-07-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Nea 15 Gp, Llc

Nea 15 Gp, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nea 15 Gp, Llc owns 21 companies in total, including Eargo Inc (EAR) , Inozyme Pharma Inc (INZY) , and Annexon Inc (ANNX) among others .

Click here to see the complete history of Nea 15 Gp, Llc’s form 4 insider trades.

Insider Ownership Summary of Nea 15 Gp, Llc

Ticker	Comapny	Transaction Date	Type of Owner
EAR	Eargo Inc	2020-10-15	10 percent owner
INZY	Inozyme Pharma Inc	2020-07-23	10 percent owner
ANNX	Annexon Inc	2020-07-23	10 percent owner
		2020-07-09	10 percent owner
		2016-05-13	10 percent owner
		2016-07-18	10 percent owner
		2019-06-07	10 percent owner
		2018-12-07	10 percent owner
		2018-03-09	10 percent owner
		2015-06-16	10 percent owner
		2016-12-19	10 percent owner
		2018-12-07	10 percent owner
		2021-04-08	10 percent owner
		2021-06-24	10 percent owner
		2020-12-09	10 percent owner
		2021-07-29	director & 10 percent owner
		2022-02-03	10 percent owner
		2021-07-21	10 percent owner
		2021-09-30	10 percent owner
		2022-06-08	10 percent owner
		2021-07-21	10 percent owner

Nea 15 Gp, Llc Latest Holdings Summary

Nea 15 Gp, Llc currently owns a total of 1 stock. Nea 15 Gp, Llc owns 5,331,039 shares of Ardelyx Inc (ARDX) as of July 18, 2016, with a value of $29 Million.

Latest Holdings of Nea 15 Gp, Llc

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ARDX	Ardelyx Inc	2016-07-18	5,331,039	5.50	29,320,715

Holding Weightings of Nea 15 Gp, Llc

Nea 15 Gp, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Nea 15 Gp, Llc has made a total of 0 transactions in Ardelyx Inc (ARDX) over the past 5 years. The most-recent trade in Ardelyx Inc is the acquisition of 1,527,301 shares on July 18, 2016, which cost Nea 15 Gp, Llc around $13 Million.

Insider Trading History of Nea 15 Gp, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nea 15 Gp, Llc Trading Performance

GuruFocus tracks the stock performance after each of Nea 15 Gp, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nea 15 Gp, Llc is 7.47%. GuruFocus also compares Nea 15 Gp, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nea 15 Gp, Llc within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Nea 15 Gp, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Nea 15 Gp, Llc

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	4.14
Relative Return to S&P 500(%)	4.35

Nea 15 Gp, Llc Ownership Network

Ownership Network List of Nea 15 Gp, Llc

No Data

Ownership Network Relation of Nea 15 Gp, Llc

Nea 15 Gp, Llc Owned Company Details

What does Eargo Inc do?

Who are the key executives at Eargo Inc?

Nea 15 Gp, Llc is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .

Eargo Inc (EAR) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 1,514 shares made by William Brownie , a net sale of 19 shares made by Adam Laponis , and a net sale of 3 shares made by Mark Thorpe .

In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,536 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,536 shares.

Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eargo Inc Insider Transactions

No Available Data

What does Inozyme Pharma Inc do?

Who are the key executives at Inozyme Pharma Inc?

Nea 15 Gp, Llc is the 10 percent owner of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and 10 percent owner Longitude Capital Partners Iii, Llc .

Inozyme Pharma Inc (INZY) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 833,333 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .

In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 1,666,666 shares were bought by its insiders, resulting in a net purchase of 1,659,143 shares.

Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inozyme Pharma Inc Insider Transactions

No Available Data

What does Annexon Inc do?

Who are the key executives at Annexon Inc?

Nea 15 Gp, Llc is the 10 percent owner of Annexon Inc. Other key executives at Annexon Inc include EVP & Chief Innovation Officer Ted Yednock , EVP & Chief Financial Officer Jennifer Lew , and EVP & Chief Business Officer Michael Overdorf .

Annexon Inc (ANNX) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Annexon Inc (ANNX). Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 74,985 shares made by Ted Yednock , a net purchase of 22,400 shares made by William H. Carson , and a net sale of 6,563 shares made by Jennifer Lew .

In summary, during the past 3 months, insiders sold 20,908 shares of Annexon Inc (ANNX) in total and bought 3,200 shares, with a net sale of 17,708 shares. During the past 18 months, 92,392 shares of Annexon Inc (ANNX) were sold and 372,400 shares were bought by its insiders, resulting in a net purchase of 280,008 shares.

Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Annexon Inc Insider Transactions

No Available Data

What does Nkarta Inc do?

Who are the key executives at Nkarta Inc?

Nea 15 Gp, Llc is the 10 percent owner of Nkarta Inc. Other key executives at Nkarta Inc include Chief Legal Officer Alicia J. Hager , Chief Medical Officer David Shook , and Sr. VP & Technical Operations Ralph Brandenberger .

Nkarta Inc (NKTX) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 9,598 shares made by James Trager , a net sale of 9,378 shares made by Alicia J. Hager , and a net sale of 5,778 shares made by David Shook .

In summary, during the past 3 months, insiders sold 0 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 41,413 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,958,587 shares.

Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nkarta Inc Insider Transactions

No Available Data

What does AVEO Pharmaceuticals Inc do?

Who are the key executives at AVEO Pharmaceuticals Inc?

Nea 15 Gp, Llc is the 10 percent owner of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .

AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

AVEO Pharmaceuticals Inc Insider Transactions

No Available Data

What does Ardelyx Inc do?

Who are the key executives at Ardelyx Inc?

Nea 15 Gp, Llc is the 10 percent owner of Ardelyx Inc. Other key executives at Ardelyx Inc include director & President & CEO Michael Raab , Chief Development Officer David P. Rosenbaum , and Chief Medical Officer Laura A Williams .

Ardelyx Inc (ARDX) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Ardelyx Inc (ARDX). Other recent insider transactions involving Ardelyx Inc (ARDX) include a net sale of 372,693 shares made by Michael Raab , a net sale of 304,930 shares made by David P. Rosenbaum , and a net sale of 495,440 shares made by Elizabeth A Grammer .

In summary, during the past 3 months, insiders sold 271,239 shares of Ardelyx Inc (ARDX) in total and bought 215,868 shares, with a net sale of 55,371 shares. During the past 18 months, 2,028,731 shares of Ardelyx Inc (ARDX) were sold and 215,868 shares were bought by its insiders, resulting in a net sale of 1,812,863 shares.

Ardelyx Inc (ARDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ardelyx Inc Insider Transactions

No Available Data

What does Nightstar Therapeutics PLC do?

Who are the key executives at Nightstar Therapeutics PLC?

Nea 15 Gp, Llc is the 10 percent owner of Nightstar Therapeutics PLC. Other key executives at Nightstar Therapeutics PLC include 10 percent owner Scott D Sandell , 10 percent owner Peter J Barris , and director & 10 percent owner David M Mott .

Nightstar Therapeutics PLC (NITE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nightstar Therapeutics PLC (NITE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nightstar Therapeutics PLC (NITE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nightstar Therapeutics PLC (NITE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nightstar Therapeutics PLC Insider Transactions

No Available Data

What does Millendo Therapeutics Inc do?

Who are the key executives at Millendo Therapeutics Inc?

Nea 15 Gp, Llc is the 10 percent owner of Millendo Therapeutics Inc. Other key executives at Millendo Therapeutics Inc include General Counsel and Secretary Tamara L Joseph , Chief Financial Officer Arcudi Iii Louis J , and director & President and CEO Julia C. Owens .

Millendo Therapeutics Inc (MLND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millendo Therapeutics Inc (MLND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millendo Therapeutics Inc (MLND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millendo Therapeutics Inc (MLND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Millendo Therapeutics Inc Insider Transactions

No Available Data

What does Cascadian Therapeutics Inc do?

Who are the key executives at Cascadian Therapeutics Inc?

Nea 15 Gp, Llc is the 10 percent owner of Cascadian Therapeutics Inc. Other key executives at Cascadian Therapeutics Inc include 10 percent owner Nea Partners 15, L.p. , 10 percent owner Florence Anthony A. Jr. , and 10 percent owner Peter W. Sonsini .

Cascadian Therapeutics Inc (CASC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cascadian Therapeutics Inc (CASC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cascadian Therapeutics Inc (CASC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cascadian Therapeutics Inc (CASC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cascadian Therapeutics Inc Insider Transactions

No Available Data

What does ARCA biopharma Inc do?

Who are the key executives at ARCA biopharma Inc?

Nea 15 Gp, Llc is the 10 percent owner of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .

ARCA biopharma Inc (ABIO) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in ARCA biopharma Inc (ABIO). Other recent insider transactions involving ARCA biopharma Inc (ABIO) include a net purchase of 634,678 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 52,890 shares were bought by its insiders, resulting in a net purchase of 52,890 shares.

ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARCA biopharma Inc Insider Transactions

No Available Data

What does Achaogen Inc do?

Who are the key executives at Achaogen Inc?

Nea 15 Gp, Llc is the 10 percent owner of Achaogen Inc. Other key executives at Achaogen Inc include 10 percent owner Robert W Duggan , Chief Operating Officer Elizabeth Bhatt , and See Remarks Gary Loeb .

Achaogen Inc (AKAOQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Achaogen Inc (AKAOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achaogen Inc (AKAOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achaogen Inc (AKAOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Achaogen Inc Insider Transactions

No Available Data

What does Tempest Therapeutics Inc do?

Who are the key executives at Tempest Therapeutics Inc?

Nea 15 Gp, Llc is the 10 percent owner of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & Chief Executive Officer Stephen R Brady , and Chief Medical Officer Samuel Whiting .

Tempest Therapeutics Inc (TPST) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Tempest Therapeutics Inc (TPST). Other recent insider transactions involving Tempest Therapeutics Inc (TPST) include a net sale of 787,999 shares made by Versant Venture Capital Vi, L.p. , a net purchase of 35,000 shares made by Stephen R Brady , and a net purchase of 4,672 shares made by Samuel Whiting .

In summary, during the past 3 months, insiders sold 0 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 787,999 shares of Tempest Therapeutics Inc (TPST) were sold and 39,672 shares were bought by its insiders, resulting in a net sale of 748,327 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tempest Therapeutics Inc Insider Transactions

No Available Data

What does Reneo Pharmaceuticals Inc do?

Who are the key executives at Reneo Pharmaceuticals Inc?

Nea 15 Gp, Llc is the 10 percent owner of Reneo Pharmaceuticals Inc. Other key executives at Reneo Pharmaceuticals Inc include Chief Development Officer Ashley Hall , 10 percent owner Novo Holdings A/s , and Senior VP & Corporate Operation Michael Cruse .

Reneo Pharmaceuticals Inc (RPHM) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Reneo Pharmaceuticals Inc (RPHM). Other recent insider transactions involving Reneo Pharmaceuticals Inc (RPHM) include a net purchase of 1,199,482 shares made by Braden Michael Leonard , a net sale of 100,000 shares made by Novo Holdings A/s , and a net sale of 15,625 shares made by Ashley Hall .

In summary, during the past 3 months, insiders sold 0 shares of Reneo Pharmaceuticals Inc (RPHM) in total and bought 51,338 shares, with a net purchase of 51,338 shares. During the past 18 months, 11,563 shares of Reneo Pharmaceuticals Inc (RPHM) were sold and 119,948 shares were bought by its insiders, resulting in a net purchase of 108,386 shares.

Reneo Pharmaceuticals Inc (RPHM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reneo Pharmaceuticals Inc Insider Transactions

No Available Data

What does NeueHealth Inc do?

Who are the key executives at NeueHealth Inc?

Nea 15 Gp, Llc is the 10 percent owner of NeueHealth Inc. Other key executives at NeueHealth Inc include Chief Financial Officer Jay Matushak , Chief Accounting Officer Jeffrey J Scherman , and director & CEO and President Mikan George Lawrence Iii .

NeueHealth Inc (NEUE) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in NeueHealth Inc (NEUE). Other recent insider transactions involving NeueHealth Inc (NEUE) include a net sale of 3,494 shares made by Jay Matushak , a net sale of 56,739 shares made by Mikan George Lawrence Iii , and a net sale of 1,436 shares made by Jeffrey J Scherman .

In summary, during the past 3 months, insiders sold 87 shares of NeueHealth Inc (NEUE) in total and bought 0 shares, with a net sale of 87 shares. During the past 18 months, 65,750 shares of NeueHealth Inc (NEUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 65,750 shares.

NeueHealth Inc (NEUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

NeueHealth Inc Insider Transactions

No Available Data

What does Desktop Metal Inc do?

Who are the key executives at Desktop Metal Inc?

Nea 15 Gp, Llc is the 10 percent owner of Desktop Metal Inc. Other key executives at Desktop Metal Inc include CHIEF OPERATING OFFICER Thomas Nogueira , CFO & TREASURER Jason M Cole , and Chief Technology Officer Jonah Myerberg .

Desktop Metal Inc (DM) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Desktop Metal Inc (DM). Other recent insider transactions involving Desktop Metal Inc (DM) include a net sale of 384,064 shares made by Jason M Cole , a net sale of 190,004 shares made by Jonah Myerberg , and a net sale of 7,298 shares made by Thomas Nogueira .

In summary, during the past 3 months, insiders sold 0 shares of Desktop Metal Inc (DM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 86,362 shares of Desktop Metal Inc (DM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 86,362 shares.

Desktop Metal Inc (DM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Desktop Metal Inc Insider Transactions

No Available Data

What does Robinhood Markets Inc do?

Who are the key executives at Robinhood Markets Inc?

Nea 15 Gp, Llc is the director & 10 percent owner of Robinhood Markets Inc. Other key executives at Robinhood Markets Inc include Chief Financial Officer Jason Warnick , director & 10 percent owner & Chief Creative Officer Baiju Bhatt , and director & 10 percent owner & Chief Executive Officer Vladimir Tenev .

Robinhood Markets Inc (HOOD) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Robinhood Markets Inc (HOOD). Other recent insider transactions involving Robinhood Markets Inc (HOOD) include a net sale of 3,106,609 shares made by Baiju Bhatt , a net sale of 4,604,068 shares made by Vladimir Tenev , and a net sale of 276,641 shares made by Gallagher Daniel Martin Jr .

In summary, during the past 3 months, insiders sold 11,816,379 shares of Robinhood Markets Inc (HOOD) in total and bought 0 shares, with a net sale of 11,816,379 shares. During the past 18 months, 18,851,515 shares of Robinhood Markets Inc (HOOD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 18,851,515 shares.

Robinhood Markets Inc (HOOD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Robinhood Markets Inc Insider Transactions

No Available Data

What does Arcellx Inc do?

Who are the key executives at Arcellx Inc?

Nea 15 Gp, Llc is the 10 percent owner of Arcellx Inc. Other key executives at Arcellx Inc include Chief Financial Officer Michelle Gilson , Chief Medical Officer Christopher Heery , and director & See Remarks Rami Elghandour .

Arcellx Inc (ACLX) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Arcellx Inc (ACLX). Other recent insider transactions involving Arcellx Inc (ACLX) include a net sale of 343,050 shares made by Christopher Heery , a net sale of 77,979 shares made by Kavita Patel , and a net sale of 69,452 shares made by Michelle Gilson .

In summary, during the past 3 months, insiders sold 96,015 shares of Arcellx Inc (ACLX) in total and bought 0 shares, with a net sale of 96,015 shares. During the past 18 months, 1,607,633 shares of Arcellx Inc (ACLX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,607,633 shares.

Arcellx Inc (ACLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arcellx Inc Insider Transactions

No Available Data

What does Berkshire Grey Inc do?

Who are the key executives at Berkshire Grey Inc?

Nea 15 Gp, Llc is the 10 percent owner of Berkshire Grey Inc. Other key executives at Berkshire Grey Inc include 10 percent owner Svf Ii Bg (de) Llc , 10 percent owner Softbank Group Corp , and director & Chief Executive Officer Thomas Anderson Wagner .

Berkshire Grey Inc (BGRY) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Berkshire Grey Inc (BGRY). Other recent insider transactions involving Berkshire Grey Inc (BGRY) include a net sale of 65,567,317 shares made by Svf Ii Bg (de) Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Berkshire Grey Inc (BGRY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 65,567,317 shares of Berkshire Grey Inc (BGRY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 65,567,317 shares.

Berkshire Grey Inc (BGRY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Berkshire Grey Inc Insider Transactions

No Available Data

What does IonQ Inc do?

Who are the key executives at IonQ Inc?

Nea 15 Gp, Llc is the 10 percent owner of IonQ Inc. Other key executives at IonQ Inc include Chief Revenue Officer Rima Alameddine , director & President and CEO Peter Hume Chapman , and Chief Financial Officer Thomas G. Kramer .

IonQ Inc (IONQ) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in IonQ Inc (IONQ). Other recent insider transactions involving IonQ Inc (IONQ) include a net sale of 205,648 shares made by Rima Alameddine , a net sale of 66,187 shares made by Thomas G. Kramer , and a net sale of 109,368 shares made by Peter Hume Chapman .

In summary, during the past 3 months, insiders sold 104,804 shares of IonQ Inc (IONQ) in total and bought 0 shares, with a net sale of 104,804 shares. During the past 18 months, 415,975 shares of IonQ Inc (IONQ) were sold and 115,005 shares were bought by its insiders, resulting in a net sale of 300,970 shares.

IonQ Inc (IONQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

IonQ Inc Insider Transactions

No Available Data

What does Senti Biosciences Inc do?

Who are the key executives at Senti Biosciences Inc?

Nea 15 Gp, Llc is the 10 percent owner of Senti Biosciences Inc. Other key executives at Senti Biosciences Inc include Chief Medical & Devt. Officer Kanya Rajangam , Chief Operating Officer Herberts Curt A. Iii , and 10 percent owner Bayer Us Holding Lp .

Senti Biosciences Inc (SNTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Senti Biosciences Inc (SNTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Senti Biosciences Inc (SNTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Senti Biosciences Inc (SNTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Senti Biosciences Inc Insider Transactions

No Available Data

What does Revolution Acceleration Acquisition Corp do?

Who are the key executives at Revolution Acceleration Acquisition Corp?

Nea 15 Gp, Llc is the 10 percent owner of Revolution Acceleration Acquisition Corp. Other key executives at Revolution Acceleration Acquisition Corp include 10 percent owner Softbank Group Corp , director & Chief Executive Officer Thomas Anderson Wagner , and See Remarks Steven Jay Johnson .

Revolution Acceleration Acquisition Corp (RAACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Revolution Acceleration Acquisition Corp (RAACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Revolution Acceleration Acquisition Corp (RAACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Revolution Acceleration Acquisition Corp (RAACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revolution Acceleration Acquisition Corp Insider Transactions

No Available Data

Nea 15 Gp, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Nea 15 Gp, Llc. You might contact Nea 15 Gp, Llc via mailing address: 1954 Greenspring Drive, Suite 600, Timonium Md 21093.

Discussions on Nea 15 Gp, Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.